Steroid hormones and pancreas: A new paradigm;Las hormonas esteroides y el páncreas: Un nuevo paradigma

Revista de Investigacion Clinica

Volumn 59, Issue 2, 2007, Pages 124-129

  Morales Miranda, Angélica ^a   Robles Díaz, Guillermo ^b   Díaz Sánchez, Vicente ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c MEXFAM AC ^*

Author keywords

Pancreatic cancer; Pancreatic function; Steroids

Indexed keywords

HORMONE ANTAGONIST; INSULIN; STEROID HORMONE; STEROID RECEPTOR;

ARTICLE; BIOTRANSFORMATION; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; GENDER; HORMONE ACTION; HUMAN; INSULIN RELEASE; INSULIN SYNTHESIS; PANCREAS CANCER; PANCREAS FUNCTION; PROTEIN EXPRESSION; STEROID METABOLISM; STEROIDOGENESIS; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GONADAL STEROID HORMONES; HORMONES; HUMANS; INSULIN; MALE; MAMMALS; MODELS, BIOLOGICAL; PANCREAS; PANCREATIC NEOPLASMS; RATS; STEROIDS;

EID: 34447256609     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kuhn T. La estructura de las revoluciones científicas. México: Fonda de Cultura Económica; 1975.
2. Camacho-Arroyo I, Gonzáles-Agüero G, Gamboa-Domínguez A, Cerbón MA, Ondanza R. Progesterone receptor isoforms expression pattern in human chordomas. J. Neuro-oncol 2000; 49: 1-7.
3. Thiboutot D, Jabara S, McAllister JM, Sivarejah A, Gilliland K, Cong Z, Clawson G. Human skin is a steroidogenic tissue steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J. Invest Dermatol 2003; 120: 905-14.
4. Gerald JP, Eugene DA. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocrine Rev 1995; 16: 608-48.
5. Muller JJ, Lapko A, Bourenkov G, Ruckpaul K, Heinemann U. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J Biol Chemistry 2001; 276: 2786-9.
6. Grinberg AV, Hannemann F, Schiffer B, Muller J, Heinemann U, Bernhardt R. Adrenodoxin structure stability and electron transfer properties. Prot Struct Func Genet 2000; 40: 590-612.
7. Rouiller V, Gangnerau MN, Vayssiere JL, Picon R. Cholesterol side-chain cleavage activity in rat fetal gonads a limiting step for ovarian steroidogenesis. Mol Cell Endocrinol 1990; 72: 111-20.
8. Pardridge WM. The transport of protein bound hormones intro tissue in vivo. Endo Rev 1981; 2: 103-23.
9. Iqbal MJ, Greenway B, Wilkinson ML, Johnson PJ, Williams R. Sex steroid enzymes aromatase and 5-α reductase in the pancreas a comparation of normal adult, foetal and malignant tissue. Mol. Science 1983; 65: 71-5.
10. Sakurai N, Miki Y, Suzuki T, Watanabe K, Narita T, Ando K, Yung TM, Aoki D, Sasano H, Handa H. Systemic distribution and tissue localizations of human 17-β-hydroxysteroid dehydrogenase type 12. J Steroid Biochem Mol Biol 2006; 99: 174-81.
11. Mendoza-Hernández G, López-Salache I, Rendón JL. 3β-hydroxysteroid dehydrogenase-isomerase activity in canine pancreas. Life Sciences 1990; 47: 467-75.
12. Fernández del Castillo C, Díaz-Sánchez V, Varela Fascinetto G, Altamirano A, Odor-Morales A, López-Medrano RM, Robles-Díaz G. Testosterone biotransformation by the isolated perfused canine pancreas. Pancreas 1991; 6: 104-6.
13. Morales A, Cuellar A, Ramirez J, Vilchis F, Diaz-Sanchez V. Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity. Pancreas 1999; 19: 39-44.
14. Bourry J, Sarles H. Secretory pattern and pathological study of the pancreas of steroid treated rats. Dig Dis Sci 1978; 23: 423-28.
15. Nieuwenhuizen AG, Schuiling GA, Liem SM, Moes H, Koiter TR, Uilenbroek JT. Progesterone stimulates pancreatic cell proliferation in vivo. Eur J Endocrinol 1999; 140: 256-63.
16. Ortsater H. Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans. Diabetes Metab Res Rev 2005; 21: 359-66.
17. Morimoto S, Fernández-Mejia C, Romero-Navarro G, Morales-Peza N, Díaz-Sánchez V. Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology 2001; 142: 1442-7.
18. Lhoste EF, Roebuck BD, Stern JE, Longnecker DS. Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat. Pancreas 1987; 1: 38-43.
19. Reddy JK, Scarpelli DG, Rao MS. Experimental pancreatic carcinogenesis. Adv Med Oncol Res Educ 1979; 9: 99-109.
20. Kalapothaki V, Tzonou A, Hsieh CC, Toupadaki N, Karakatsani A, Trichoulos D. Tabacco, ethanol, coffee, pancreatitis, diabetes mellitus and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 1993; 4: 375-82.
21. Wang XL, Wang J. Smoking-gene interaction and disease development relevance to pancreatic cancer and atherosclerosis. World J Surgery 2005; 29: 344-53.
22. Marchese R, Muleti A, Pasqualetti P, Bucci B, Stigliano A, Brunetti E, De Angelis M, Mazzoni G, Tocchi A, Brozzetti S. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA. Pancreas 2006; 32: 171-7.
23. Jeong J, Park YN, Park JS, Yoon DS, Chi HS, Kim BR. Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer. Yonsei Med J 2005; 46: 519-25.
24. Greenway B, Iqbal MJ, Johnson PJ, Williams R. Low serum testosterone concentration in patients with carcinoma of the pancreas. Br Med J 1983; 286: 93-5.
25. Robles-Díaz G, Díaz-Sánchez V, Fernández del Castillo C, Morales M, Aceves G, Galván Elba, Altamirano A. Serum testosterone/dihydrotestosterone ratio and CA-19-9 in the diagnosis of pancreatic cancer. American J. Gastroenterol 1991; 86: 591-94.
26. Fernández-del Castillo C, Robles-Díaz G, Díaz-Sánchez V, Altamirano A. Pancreatic cancer and androgen metabolism high androstendione and low testosterone serum levels. Páncreas 1990; 5: 515-18.
27. Fyssas I, Syrigos KN, Konstandoulakis MM, Papadopoulos S, Milingos N, Anapliotou M, Waxman J, Golematis BC. Sex hormone levels in the serum of patients with pancreatic adenocarcinoma. Horm Metab Res 1997; 29: 115-8.
28. Lygidakis NJ, Jain S, Sacchi M, Vrachnos P. Adenocarcinoma of the pancreas past, present and future. Hepatogastroenterology 2005; 52: 1281-92.
29. Andren-Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects. Annals Oncology 1999; 10: 131-3529.
30. Fernandez E, Lavecchia C, Davanzo B, Negri E. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 1995; 62: 11-14.
31. Brugge W, Lauwers GY, Shahani D, Fernandez del Castillo C, Warshaw A. Cystic neoplasms of the pancreas. N Engl J Med 2004; 351: 1218-25.
32. Ganepola GA, Gritsman AY, Asimakopulos N, Yiengpruksawas A. Are pancreatic tumors hormone dependent? A case report of unusual, rapidly growing pancreatic tumor during pregnancy, its possible relatioship to female sex hormones, and review of the literature. Am Surg 1999; 65: 105-11.
33. Morales A, Ruiz-Molina JM, Orozco H, Robles-Díaz G, Díaz-Sánchez V. Papillary-cystic neoplasm of the pancreas a sex steroid dependent tumor. Int. J. Pancreatology 1998; 24: 219-25.
34. Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer a decision analysis. Cancer 2006; 106: 2576-82.
35. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985; 45: 3415-43.
36. Yamashita J, Abe M, Ogawa M. Endocrine therapy in pancreatic carcinoma. Oncology. 1998; 55: 17-22.
37. Greenway BA. Androgen receptor-blocking agents: potential role in pancreatic cancer. Drugs Aging 2000; 17: 161-3.
38. Abe M, Yamashita J, Ogawa M. Medroxyprogeterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Cancer 2000; 88: 20009.
39. Negi SS, Agarwal A, Chaudhary A. Flutamide in unresectable pancreatic adenocarcinoma: a randomized, double-blind, placebo-controlled trial. Invest New Drugs 2006, 24: 189-94.
40. Bakkevold KE, Pettersen A, Arnesjo B, Espehaug B. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of vater. Br J Surg 1990; 77: 725-3O.